摘要
目的探讨尿微量白蛋白检测在2型糖尿病(T2DM)患者中的临床价值。方法随机选取临床确诊的60例T2DM患者,另将60例健康体检者作为对照组。2组分别测定空腹血糖和尿微量白蛋白。结果对照组空腹血糖和尿微量白蛋白分别为(4.82±1.59)mmol/L和(18.60±4.48)mg/d,T2DM组空腹血糖和尿微量白蛋白数值较对照组明显升高,分别为(15.65±4.97)mmol/L和(64.77±11.59)mg/d,2组比较差异有统计学意义(P<0.01)。结论 T2DM患者微量白蛋白尿发生率较高,尿微量白蛋白检测可以作为T2DM患者的常规检查项目。
Objective To discuss the clinical significance of the testing MAU on the patients of T2DM. Method To select 60 confirmed T2DM patients at random, and set 60 healthy persons in a group for comparative study. Both groups were tested for fasting blood sugar and MAU. Results The fasting blood sugar figure and the MAU figure of the comparison group were （4.82±1.59） mmol/L and （18.60±4.48） mg/d, while the same figures of the T2DM group were markedly higher than the comparison group, registering at （15.65 ±4.97） mmol/L and （64.77 ±11.59） mg/d. The differences of the two groups were statistically significant （P〈0.01）. Conclusion MAU occurs rather frequently among T2DM patients, and a test of MAU can be made a content of regular examination for T2 DM patients.
出处
《保健医学研究与实践》
2014年第1期60-61,共2页
Health Medicine Research and Practice
